Latest BRCA mutation Stories
WILMINGTON, Del., Dec. 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved LYNPARZA(TM) (olaparib) capsules.
Gayle Brinkenhoff Inaugural Symposium: Genome, Damage and Repair in Breast Cancer VENTURA, Calif., Dec.
First major service extension to the company's BRCAvantage(TM) BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancer MADISON,
HealthForumOnline (HFO) has recently updated The Psychosocial Needs of Women Undergoing Genetic Counseling and Testing in the Breast Cancer Context, an online continuing education (CE) course
Angelina Jolie’s decision to have a double mastectomy after being told she would likely develop breast cancer had a tremendous impact on testing for the disease in the UK, the authors of a new Breast Cancer Journal study reported on Friday.
GILBERT, Ariz., Aug.
Women with mutations in the PALB2 gene have on average a one in three chance of developing breast cancer by the age of seventy.
AllMed webinar provides in-depth review of the latest in standard of care for the genetic testing of breast and ovarian cancer. Portland, Oregon (PRWEB) June
Around a quarter of smokers who carry a defect in the BRCA2 gene will develop lung cancer at some point in their lifetime.
Mutations in the BRCA1 and BRCA2 genes account for nearly 25 percent of hereditary breast cancers and most hereditary ovarian cancers, yet a study by cancer prevention and control researchers at Virginia Commonwealth University Massey Cancer Center suggests an alarmingly small amount of women who qualify for BRCA genetic counseling actually receive the services.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.